BioCorRx Inc.
BICX· OTC
BICXBioCorRx Inc.
Quarterly figures for BioCorRx Inc., with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
BioCorRx Inc. has filed its 10-Q within 44 to 45 days of period end across its last 8 quarters. The 10-K runs 90 to 106 days.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $87.97K | −50.6% | -$0.03 | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | $214.54K | +59.0% | -$0.03 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 31, 2026 | 90 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 31, 2025 | 90 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 1, 2024 | 92 d | 10-K | $18.94K | −77.2% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 14, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | $82.88K | +508.8% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | ||||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 31, 2022 | 90 d | 10-K | $13.61K | −38.7% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Mar 31, 2021 | 90 d | 10-K | $22.22K | −64.4% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 16, 2020 | ||||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | Mar 30, 2020 | 90 d | 10-K | $62.45K | +20.8% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 14, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Apr 16, 2019 | 106 d | 10-K | $51.67K | −68.7% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | ||||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | Apr 5, 2018 | 95 d | 10-K | $164.91K | +42.3% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 14, 2017 | ||||||
| FY 2016 | |||||||||
| Q4 2016derived | Dec 31, 2016 | — | Apr 13, 2017 | 103 d | 10-K | $115.85K | +58.1% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 17, 2016 | ||||||
| FY 2015 | |||||||||
| Q4 2015derived | Dec 31, 2015 | — | Apr 14, 2016 | 105 d | 10-K | $73.30K | −80.1% | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 16, 2015 | ||||||
| FY 2014 | |||||||||
| Q4 2014derived | Dec 31, 2014 | — | Mar 31, 2015 | 90 d | 10-K | $368.04K | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 10, 2014 | ||||||
| FY 2013 | |||||||||
| Q4 2013derived | Dec 31, 2013 | — | Apr 14, 2014 | 104 d | 10-K | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 14, 2013 | 45 d | 10-Q | ||||
| FY 2012 | |||||||||
| Q4 2012derived | Dec 31, 2012 | — | Apr 15, 2013 | 105 d | 10-K | $364.10K | +289.1% | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 19, 2012 | ||||||
| FY 2011 | |||||||||
| Q4 2011derived | Dec 31, 2011 | — | May 18, 2012 | 139 d | 10-K | $93.57K | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 21, 2011 | ||||||
| FY 2010 | |||||||||
| Q4 2010derived | Dec 31, 2010 | — | Apr 15, 2011 | 105 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 19, 2010 | 50 d | 10-Q | ||||
| $635.22K |
| — |
| -$0.11 |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | $178.24K | +4,306.4% | -$0.07 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | $134.90K | +3,626.5% | -$0.06 |
|---|
| 45 d |
| 10-Q |
| $0.00 |
| −100.0% |
| -$0.14 |
| Q2 2024 | Jun 30, 2024 | — | Aug 13, 2024 | 44 d | 10-Q | $4.05K | −79.4% | -$0.13 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $3.62K | −91.0% | — |
|---|
| 45 d |
| 10-Q |
| $10.15K |
| −89.3% |
| — |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $19.64K | +22.7% | — |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | $40.44K | +97.1% | — |
|---|
| 45 d |
| 10-Q |
| $94.44K |
| +971.1% |
| — |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | $16.00K | +1.8% | — |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | $20.52K | +102.7% | — |
|---|
| 46 d |
| 10-Q |
| $8.82K |
| −70.4% |
| -$0.21 |
| Q2 2021 | Jun 30, 2021 | — | Aug 13, 2021 | 44 d | 10-Q | $15.72K | −53.4% | -$0.16 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | $10.12K | −72.6% | -$0.26 |
|---|
| 47 d |
| 10-Q |
| $29.81K |
| −36.0% |
| -$0.14 |
| Q2 2020 | Jun 30, 2020 | — | Aug 14, 2020 | 45 d | 10-Q | $33.70K | −48.9% | -$0.14 |
|---|
| Q1 2020 | Mar 31, 2020 | — | May 15, 2020 | 45 d | 10-Q | $36.90K | −43.5% | -$0.20 |
|---|
| 45 d |
| 10-Q |
| $46.56K |
| −40.8% |
| -$0.33 |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | $65.98K | −33.1% | -$0.67 |
|---|
| Q1 2019 | Mar 31, 2019 | — | May 15, 2019 | 45 d | 10-Q | $65.27K | −55.8% | -$0.67 |
|---|
| 45 d |
| 10-Q |
| $78.58K |
| −46.8% |
| -$0.75 |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | $98.67K | −53.1% | $0.00 |
|---|
| Q1 2018 | Mar 31, 2018 | — | May 18, 2018 | 48 d | 10-Q | $147.72K | +10.1% | -$0.41 |
|---|
| 45 d |
| 10-Q |
| $147.59K |
| −11.9% |
| $0.00 |
| Q2 2017 | Jun 30, 2017 | — | Aug 11, 2017 | 42 d | 10-Q | $210.54K | +12.0% | $0.02 |
|---|
| Q1 2017 | Mar 31, 2017 | — | May 15, 2017 | 45 d | 10-Q | $134.23K | −41.7% | -$0.19 |
|---|
| 48 d |
| 10-Q |
| $167.60K |
| +41.8% |
| -$0.02 |
| Q2 2016 | Jun 30, 2016 | — | Aug 17, 2016 | 48 d | 10-Q | $187.91K | −59.0% | -$0.01 |
|---|
| Q1 2016 | Mar 31, 2016 | — | May 23, 2016 | 53 d | 10-Q | $230.41K | −16.4% | $0.00 |
|---|
| 47 d |
| 10-Q |
| $118.19K |
| −72.8% |
| $0.00 |
| Q2 2015 | Jun 30, 2015 | — | Aug 12, 2015 | 43 d | 10-Q | $457.78K | +92.3% | -$0.02 |
|---|
| Q1 2015 | Mar 31, 2015 | — | May 15, 2015 | 45 d | 10-Q | $275.47K | +110.6% | $0.00 |
|---|
| 41 d |
| 10-Q |
| $434.04K |
| +56.5% |
| $0.00 |
| Q2 2014 | Jun 30, 2014 | — | Aug 14, 2014 | 45 d | 10-Q | $238.01K | −52.4% | $0.00 |
|---|
| Q1 2014 | Mar 31, 2014 | — | May 14, 2014 | 44 d | 10-Q | $130.83K | −66.2% | -$0.01 |
|---|
| $277.41K |
| +333.6% |
| $0.00 |
| Q2 2013 | Jun 30, 2013 | — | Aug 19, 2013 | 50 d | 10-Q | $499.95K | +179.0% | $0.00 |
|---|
| Q1 2013 | Mar 31, 2013 | — | May 15, 2013 | 45 d | 10-Q | $387.21K | +48.4% | $0.00 |
|---|
| 50 d |
| 10-Q |
| $63.97K |
| −81.4% |
| $0.00 |
| Q2 2012 | Jun 30, 2012 | — | Aug 14, 2012 | 45 d | 10-Q | $179.21K | −41.3% | $0.00 |
|---|
| Q1 2012 | Mar 31, 2012 | — | Jul 10, 2012 | 101 d | 10-Q | $260.88K | +810.6% | $0.00 |
|---|
| 52 d |
| 10-Q |
| $344.31K |
| — |
| $0.00 |
| Q2 2011 | Jun 30, 2011 | — | Aug 16, 2011 | 47 d | 10-Q | $305.23K | — | $0.00 |
|---|
| Q1 2011 | Mar 31, 2011 | — | May 23, 2011 | 53 d | 10-Q | $28.65K | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2010 | Jun 30, 2010 | — | Aug 16, 2010 | 47 d | 10-Q | — | — | — |
|---|
